|Text of Recommendation|| |
We recommend that the Food and Drug Administration promptly resolve the 32 outstanding audit recommendations (166 that were past due as of September 30, 2016, less 134 resolved after the end of our audit period).
|Recommendation Number|| |
|Recommendation Status|| |
|Significant Recommendation|| |
|Recommendation Questioned Costs|| |
|Recommendation Funds for Better Use|| |